Get startedLog in
    Picture of Intelgenx Technologies logo

    IGX — Intelgenx Technologies News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    All News

    Brief: IntelGenx submits Montelukast VersaFilm(tm) clinical trial application with Health Canada

    Picture of Intelgenx Technologies logoIntelgenx Technologies
    09/11/2017 21:05
    Nov 9 (Reuters) - IntelGenx Technologies Corp  IGX.V  
    * IntelGenx submits Montelukast VersaFilm(tm) clinical trial 
application with Health Canada 
    * IntelGenx - submitted CTA to Health Canada for approval 
to 
initiate its Phase 2a POC study with Montelukast in mild to 
moderate alzheimer's disease 
 
Source text for Eikon:  ID:nMKWbtqcTa  
Further company coverage:  IGX.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;;))

    Recent news on Intelgenx Technologies

    See all news